Technology Assisted Intervention for the Treatment and Prevention of Depression
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Depression
- Sponsor
- Northwestern University
- Enrollment
- 2010
- Locations
- 1
- Primary Endpoint
- Depression, as assessed the Patient Health Questionnaire-9
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
Investigators are evaluating the use of phone sensor data to estimate behavior, depression and anxiety.
Detailed Description
Investigators are evaluating the use of phone sensor data to estimate behavior, depression and anxiety. Participants will include people who are high on depression, high on anxiety, hight on both depression and anxiety, and health controls. Particpants will load software on their phones that collects phone sensor data, and obtains self report on sleep, mood, and social contacts. Data will be collected for at least 6 weeks.
Investigators
David Mohr
Director, Center for Behavioral Intervention Technologies; Professor, Department of Preventive Medicine
Northwestern University
Eligibility Criteria
Inclusion Criteria
- •PHQ-9 score 10 or higher
- •Has an e-mail account, computer, and broadband access to the Internet
- •Familiarity with mobile phones and is within a cellular network range the majority of the day.
- •Is able to speak and read English.
- •Is at least 19 years of age.
Exclusion Criteria
- •Hearing or voice impairment preventing participation in psychotherapy.
- •Visual impairment that would prevent use of the website, mobile phone application, and assessment materials.
- •Has any psychiatric condition for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous (e.g., psychotic disorders, bipolar disorders, dissociative disorders, etc.).
- •Planning to be out of town or unavailable for intervention for 1 or more weeks during the scheduled study participation.
- •Exhibits severe suicidality, including ideation, plan, and intent.
Outcomes
Primary Outcomes
Depression, as assessed the Patient Health Questionnaire-9
Time Frame: Baseline, Weeks 2-6
Secondary Outcomes
- Positive Affect (PANAS - Positive Affect Scale)(Baseline, Weeks 2-6)
- Anxiety (GAD-7)(Baseline, Weeks 2-6)